{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-026816","form_type":"8-K","ticker":"WINT","cik":"0000946486","company_name":"WINDTREE THERAPEUTICS INC /DE/","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.463867+00:00","generated_at":"2026-05-31T09:33:08.737760+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Windtree Therapeutics board reshuffled: two directors exit, two appointed, lead independent director named","bullets":["Daniel Geffken and Leslie J. Williams resigned from the Board August 13, 2024; no disagreement with company.","Board appointed Jed Latkin and Saundra Pelletier as directors; Latkin chairs Audit, Pelletier chairs Compensation.","Mark Strobeck, Ph.D., appointed lead independent director effective August 13, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-026816","json":"https://secwatch.observer/filing/0001437749-24-026816.json","markdown":"https://secwatch.observer/filing/0001437749-24-026816.md","text":"https://secwatch.observer/filing/0001437749-24-026816.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/wint20240812_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:33:08.737760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1d3fe5ebdd","claim":"Jed Latkin was appointed as Director at WINDTREE THERAPEUTICS INC /DE/.","evidence_excerpt":"On August 13, 2024, the Board appointed Jed Latkin and Saundra Pelletier to fill the vacancies created by the resignation of Mr. Geffken and Ms. Williams, effective August 13, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4c9ab4bc68","claim":"Daniel Geffken resigned as Director at WINDTREE THERAPEUTICS INC /DE/.","evidence_excerpt":"On August 13, 2024, Daniel Geffken and Leslie J. Williams each notified Windtree Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), including all committees of the Board on which he or she serves, effective August 13, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b5b5c7a47b","claim":"Leslie J. Williams resigned as Director at WINDTREE THERAPEUTICS INC /DE/.","evidence_excerpt":"On August 13, 2024, Daniel Geffken and Leslie J. Williams each notified Windtree Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), including all committees of the Board on which he or she serves, effective August 13, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c6c0fb846f","claim":"Saundra Pelletier was appointed as Director at WINDTREE THERAPEUTICS INC /DE/.","evidence_excerpt":"On August 13, 2024, the Board appointed Jed Latkin and Saundra Pelletier to fill the vacancies created by the resignation of Mr. Geffken and Ms. Williams, effective August 13, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924026816/0001437749-24-026816-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}